{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T02:18:43Z","timestamp":1791944323966,"version":"4.3.4"},"reference-count":42,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T00:00:00Z","timestamp":1674086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Intramural Research Program at the National Institutes of Health (NIH)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Genes"],"abstract":"<jats:p>CAH-X is a hypermobility-type Ehlers\u2013Danlos syndrome connective tissue dysplasia affecting approximately 15% of patients with 21-hydroxylase deficiency (21-OHD) congenital adrenal hyperplasia (CAH) due to contiguous deletion of CYP21A2 and TNXB genes. The two most common genetic causes of CAH-X are CYP21A1P-TNXA\/TNXB chimeras with pseudogene TNXA substitution for TNXB exons 35\u201344 (CAH-X CH-1) and TNXB exons 40\u201344 (CAH-X CH-2). A total of 45 subjects (40 families) from a cohort of 278 subjects (135 families of 21-OHD and 11 families of other conditions) were found to have excessive TNXB exon 40 copy number as measured by digital PCR. Here, we report that 42 subjects (37 families) had at least one copy of a TNXA variant allele carrying a TNXB exon 40 sequence, whose overall allele frequency was 10.3% (48\/467). Most of the TNXA variant alleles were in cis with either a normal (22\/48) or an In2G (12\/48) CYP21A2 allele. There is potential interference with CAH-X molecular genetic testing based on copy number assessment, such as with digital PCR and multiplex ligation-dependent probe amplification, since this TNXA variant allele might mask a real copy number loss in TNXB exon 40. This interference most likely happens amongst genotypes of CAH-X CH-2 with an in trans normal or In2G CYP21A2 allele.<\/jats:p>","DOI":"10.3390\/genes14020265","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T07:57:38Z","timestamp":1674115058000},"page":"265","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Pseudogene TNXA Variants May Interfere with the Genetic Testing of CAH-X"],"prefix":"10.3390","volume":"14","author":[{"given":"Qizong","family":"Lao","sequence":"first","affiliation":[{"name":"National Institutes of Health Clinical Center, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiet","family":"Zhou","sequence":"additional","affiliation":[{"name":"National Institutes of Health Clinical Center, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1096-9662","authenticated-orcid":false,"given":"Megan","family":"Parker","sequence":"additional","affiliation":[{"name":"National Institutes of Health Clinical Center, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7959-9842","authenticated-orcid":false,"given":"Fabio R.","family":"Faucz","sequence":"additional","affiliation":[{"name":"The Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah P.","family":"Merke","sequence":"additional","affiliation":[{"name":"National Institutes of Health Clinical Center, Bethesda, MD 20892, USA"},{"name":"The Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD 20892, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,19]]},"reference":[{"key":"ref_1","first-page":"650","article-title":"High frequency of nonclassical steroid 21-hydroxylase deficiency","volume":"37","author":"Speiser","year":"1985","journal-title":"Am. J. Hum. Genet."},{"key":"ref_2","first-page":"1276","article-title":"Revisiting the prevalence of nonclassic congenital adrenal hyperplasia in US Ashkenazi Jews and Caucasians","volume":"19","author":"Morissette","year":"2017","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/ng0997-104","article-title":"Tenascin-X deficiency is associated with Ehlers-Danlos syndrome","volume":"17","author":"Burch","year":"1997","journal-title":"Nat. Genet."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMoa002939","article-title":"A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency","volume":"345","author":"Schalkwijk","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1086\/376564","article-title":"Haploinsufficiency of TNXB is associated with hypermobility type of Ehlers-Danlos syndrome","volume":"73","author":"Zweers","year":"2003","journal-title":"Am. J. Hum. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"E379","DOI":"10.1210\/jc.2012-3148","article-title":"Tenascin-X haploinsufficiency associated with Ehlers-Danlos syndrome in patients with congenital adrenal hyperplasia","volume":"98","author":"Merke","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"E1143","DOI":"10.1210\/jc.2015-2232","article-title":"Broadening the Spectrum of Ehlers Danlos Syndrome in Patients With Congenital Adrenal Hyperplasia","volume":"100","author":"Morissette","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1159\/000481911","article-title":"Tenascin-X, Congenital Adrenal Hyperplasia, and the CAH-X Syndrome","volume":"89","author":"Miller","year":"2018","journal-title":"Horm. Res. Paediatr."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jmoldx.2019.06.001","article-title":"High-Throughput Screening for CYP21A1P-TNXA\/TNXB Chimeric Genes Responsible for Ehlers-Danlos Syndrome in Patients with Congenital Adrenal Hyperplasia","volume":"21","author":"Lao","year":"2019","journal-title":"J. Mol. Diagn. JMD"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1210\/clinem\/dgaa199","article-title":"The Prevalence of the Chimeric TNXA\/TNXB Gene and Clinical Symptoms of Ehlers-Danlos Syndrome with 21-Hydroxylase Deficiency","volume":"105","author":"Gao","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e2789","DOI":"10.1210\/clinem\/dgab033","article-title":"Ehlers-Danlos Syndrome: Molecular and Clinical Characterization of TNXA\/TNXB Chimeras in Congenital Adrenal Hyperplasia","volume":"106","author":"Marino","year":"2021","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Paragliola, R.M., Perrucci, A., Foca, L., Urbani, A., and Concolino, P. (2022). Prevalence of CAH-X Syndrome in Italian Patients with Congenital Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency. J. Clin. Med., 11.","DOI":"10.20944\/preprints202206.0329.v1"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/s41431-020-0653-5","article-title":"EMQN best practice guidelines for molecular genetic testing and reporting of 21-hydroxylase deficiency","volume":"28","author":"Hoeppner","year":"2020","journal-title":"Eur. J. Hum. Genet. EJHG"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1038\/s41431-021-00870-5","article-title":"Molecular genetic testing of congenital adrenal hyperplasia due to 21-hydroxylase deficiency should include CAH-X chimeras","volume":"29","author":"Lao","year":"2021","journal-title":"Eur. J. Hum. Genet. EJHG"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1038\/s41431-021-00869-y","article-title":"Reply to Lao Q and Merke DP","volume":"29","author":"Hoeppner","year":"2021","journal-title":"Eur. J. Hum. Genet. EJHG"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1084\/jem.191.12.2183","article-title":"Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in caucasians. The load of RCCX genetic diversity on major histocompatibility complex-associated disease","volume":"191","author":"Blanchong","year":"2000","journal-title":"J. Exp. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"E161","DOI":"10.1210\/jc.2010-0319","article-title":"Comprehensive genetic analysis of 182 unrelated families with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"96","author":"Finkielstain","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1073\/pnas.1300057110","article-title":"Genotype-phenotype correlation in 1,507 families with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency","volume":"110","author":"New","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJMra1909786","article-title":"Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency","volume":"383","author":"Merke","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s40291-018-0319-y","article-title":"Congenital Adrenal Hyperplasia (CAH) due to 21-Hydroxylase Deficiency: A Comprehensive Focus on 233 Pathogenic Variants of CYP21A2 Gene","volume":"22","author":"Concolino","year":"2018","journal-title":"Mol. Diagn. Ther."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1093\/clinchem\/46.5.606","article-title":"Analysis of the Chimeric CYP21P\/CYP21 Gene in Steroid 21-Hydroxylase Deficiency","volume":"46","author":"Lee","year":"2000","journal-title":"Clin. Chem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1373\/clinchem.2011.174037","article-title":"Junction site analysis of chimeric CYP21A1P\/CYP21A2 genes in 21-hydroxylase deficiency","volume":"58","author":"Chen","year":"2012","journal-title":"Clin. Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.0.CO;2-O","article-title":"Ehlers-Danlos syndromes: Revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK)","volume":"77","author":"Beighton","year":"1998","journal-title":"Am. J. Med. Genet."},{"key":"ref_25","unstructured":"Adam, M.P., Everman, D.B., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Gripp, K.W., and Amemiya, A. (1993). Hypermobile Ehlers-Danlos Syndrome. GeneReviews(\u00ae), University of Washington."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1083\/jcb.122.1.265","article-title":"Tenascin-X: A novel extracellular matrix protein encoded by the human XB gene overlapping P450c21B","volume":"122","author":"Bristow","year":"1993","journal-title":"J. Cell Biol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1111\/j.1399-0004.2005.00401.x","article-title":"Elastic fiber abnormalities in hypermobility type Ehlers-Danlos syndrome patients with tenascin-X mutations","volume":"67","author":"Zweers","year":"2005","journal-title":"Clin. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1002\/ajmg.a.33092","article-title":"The phenotypic spectrum of contiguous deletion of CYP21A2 and tenascin XB: Quadricuspid aortic valve and other midline defects","volume":"149A","author":"Chen","year":"2009","journal-title":"Am. J. Med. Genetics. Part A"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e1556","DOI":"10.1002\/mgg3.1556","article-title":"A TNXB splice donor site variant as a cause of hypermobility type Ehlers-Danlos syndrome in patients with congenital adrenal hyperplasia","volume":"9","author":"Lao","year":"2021","journal-title":"Mol. Genet. Genom. Med."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1002\/humu.23028","article-title":"Ehlers-Danlos Syndrome Caused by Biallelic TNXB Variants in Patients with Congenital Adrenal Hyperplasia","volume":"37","author":"Chen","year":"2016","journal-title":"Hum. Mutat."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1373\/clinchem.2018.286823","article-title":"Validation of an Expanded Carrier Screen that Optimizes Sensitivity via Full-Exon Sequencing and Panel-wide Copy Number Variant Identification","volume":"64","author":"Hogan","year":"2018","journal-title":"Clin. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jmoldx.2013.06.001","article-title":"Comprehensive mutation analysis of the CYP21A2 gene: An efficient multistep approach to the molecular diagnosis of congenital adrenal hyperplasia","volume":"15","author":"Xu","year":"2013","journal-title":"J. Mol. Diagn. JMD"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00439-018-1959-z","article-title":"Complement component 4 variations may influence psychopathology risk in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"137","author":"Lao","year":"2018","journal-title":"Hum. Genet."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Kolli, V., Kim, H., Rao, H., Lao, Q., Gaynor, A., Milner, J.D., and Merke, D.P. (2019). Measurement of serum tenascin-X in patients with congenital adrenal hyperplasia at risk for Ehlers-Danlos contiguous gene deletion syndrome CAH-X. BMC Res. Notes, 12.","DOI":"10.1186\/s13104-019-4753-7"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S1525-1578(10)60550-8","article-title":"Validation and clinical application of a locus-specific polymerase chain reaction- and minisequencing-based assay for congenital adrenal hyperplasia (21-hydroxylase deficiency)","volume":"7","author":"Redman","year":"2005","journal-title":"J. Mol. Diagn. JMD"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1210\/jcem.87.2.8273","article-title":"Using Real-Time, Quantitative PCR for Rapid Genotyping of the Steroid 21-Hydroxylase Gene in a North Florida Population","volume":"87","author":"Olney","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1373\/clinchem.2010.156893","article-title":"Sequence analysis of CYP21A1P in a German population to aid in the molecular biological diagnosis of congenital adrenal hyperplasia","volume":"57","author":"Baade","year":"2011","journal-title":"Clin. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.ab.2011.02.016","article-title":"Analysis of the CYP21A1P pseudogene: Indication of mutational diversity and CYP21A2-like and duplicated CYP21A2 genes","volume":"413","author":"Tsai","year":"2011","journal-title":"Anal. Biochem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.gene.2012.06.045","article-title":"Analysis of CYP21A1P and the duplicated CYP21A2 genes","volume":"506","author":"Tsai","year":"2012","journal-title":"Gene"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cca.2012.12.030","article-title":"Variants of the CYP21A2 and CYP21A1P genes in congenital adrenal hyperplasia","volume":"418","author":"Lee","year":"2013","journal-title":"Clin. Chim. Acta Int. J. Clin. Chem."},{"key":"ref_41","first-page":"910","article-title":"Standard enrichment methods for targeted next-generation sequencing in high-repeat genomic regions","volume":"15","author":"Mueller","year":"2013","journal-title":"Genet. Med. Off. J. Am. Coll. Med. Genet."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/nature19057","article-title":"Analysis of protein-coding genetic variation in 60,706 humans","volume":"536","author":"Lek","year":"2016","journal-title":"Nature"}],"container-title":["Genes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4425\/14\/2\/265\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:10:46Z","timestamp":1760119846000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4425\/14\/2\/265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,19]]},"references-count":42,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["genes14020265"],"URL":"https:\/\/doi.org\/10.3390\/genes14020265","relation":{},"ISSN":["2073-4425"],"issn-type":[{"value":"2073-4425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,19]]}}}